Abstract
BACKGROUND: Hospital treatment costs of lung transplantation are insufficiently analyzed. Accordingly, it remains unknown, whether current Diagnosis Related Groups, merely accounting for 3 ventilation time intervals and length of hospital stay, reproduce costs properly, even when an increasing number of complex recipients are treated. Therefore, in this cost determination study, actual costs were calculated and cost drivers identified. METHODS: A standardized microcosting approach allowed for individual cost calculations in 780 lung transplant patients taken care of at Hannover Medical School and University of Munich from 2009 to 2013. A generalized linear model facilitated the determination of characteristics predictive for inpatient costs. RESULTS: Lung transplantation costs varied substantially by major diagnosis, with a mean of 85,946 (median 52,938 3,081). Length of stay and ventilation time properly reproduced costs in many cases. However, complications requiring prolonged ventilation or reinterventions were identified as additional significant cost drivers, responsible for high costs. CONCLUSIONS: Diagnosis Related Groups properly reproduce actual lung transplantation costs in straightforward cases, but costs in complex cases may remain underestimated. Improved grouping should consider major diagnosis, a higher gradation of ventilation time, and the number of reinterventions to allow for more reasonable reimbursement. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Betriebswirtschaft
Medizin |
Themengebiete: | 300 Sozialwissenschaften > 330 Wirtschaft
600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 1053-2498 |
Sprache: | Englisch |
Dokumenten ID: | 43428 |
Datum der Veröffentlichung auf Open Access LMU: | 27. Apr. 2018, 08:03 |
Letzte Änderungen: | 04. Nov. 2020, 13:18 |